Issue 29, 2022

Photocatalytic glucose-appended bio-compatible Ir(iii) anticancer complexes

Abstract

Rationally-designed glucose-appended Ir(III) photo-catalysts ([Ir(N,C)2(N,N-Glc)]+, Ir1–Ir3) show visible light-induced catalytic NAD(P)H oxidation in aqueous solution. The highly in vivo biocompatible complex, Ir3, shows lysosome and mitochondria targeting necro-apoptotic photo-cytotoxicity against various cancer cell lines and multicellular spheroids, while remaining non-toxic in the dark.

Graphical abstract: Photocatalytic glucose-appended bio-compatible Ir(iii) anticancer complexes

Supplementary files

Article information

Article type
Communication
Submitted
12 Apr 2022
Accepted
18 Jun 2022
First published
20 Jun 2022

Dalton Trans., 2022,51, 10875-10879

Photocatalytic glucose-appended bio-compatible Ir(III) anticancer complexes

Z. Zhu, L. Wei, Y. Lai, O. W. L. Carter, S. Banerjee, P. J. Sadler and H. Huang, Dalton Trans., 2022, 51, 10875 DOI: 10.1039/D2DT01134D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements